
A liquid biopsy test can identify patients who may respond to immune checkpoint blockade
A new liquid biopsy test could detect microsatellite instability (MSI) and tumour mutational burden (TMB),…
A new liquid biopsy test could detect microsatellite instability (MSI) and tumour mutational burden (TMB),…
Cancer cells arise when DNA is mutated, and these cells should be recognised as “foreign”…
By Professor Ian Olver AM, for oncologynews.com.au. There has been a rapid paradigm shift in anticancer treatment…
Treatment with the immune checkpoint inhibitor nivolumab (Opdivo) yielded durable responses in some patients with…